drugset / Trial / NCT05157711

Clinical Trial of Anusol Ointment for Symptom Relief in Patients With Haemorrhoids

NCT05157711

Phase 3 Completed 66 enrolled Church & Dwight Company, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Anusol topical ointment for the relief of internal and external haemorrhoid symptoms in people with Grades I-III haemorrhoids compared to a placebo (the study medication without the active ingredients) and a benchmark product.

Timeline

Start
2021-11-25
Primary completion
2022-03-31
Completion
2022-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Anusol Unknown Topical
Comparator Phenylephrine Small molecule Rectal

Indications